FTC Emerges as Another Obstacle to Health Reform Law

FTC Emerges as Another Obstacle to Health Reform Law

The Affordable Care Act pushes new efforts at health care provider integration, like accountable care organizations, that may lead to more market concentration. The Federal Trade Commission is stepping up efforts to stop provider consolidation. Which approach will win out?

Many assessments of the Affordable Care Act’s long-term viability have focused on Congress’ ability to weaken or repeal the law, especially if Democrats lose both chambers in 2012. Others are looking ahead to the Supreme Court’s potential impact on the individual mandate’s constitutionality.

But another Washington, D.C. player — the Federal Trade Commission — is already creating problems for the Obama administration.

True to its name, the Affordable Care Act tries out a number of new ideas to make health care less expensive. As one tactic, the law provides incentives for the creation of accountable care organizations to care for dedicated populations of Medicare beneficiaries.

However, the White House and FTC don’t see eye to eye on ACOs’ antitrust implications. The White House — and by extension, the Department of Justice — has viewed ACOs through the lens of consumer benefit. Meanwhile, the FTC spots a risk that ACOs could help already strong health care providers further fix prices.

The divide has fueled a highly unusual public split — with one official complaining to the Wall Street Journal that DOJ and FTC resorted to coin flips to solve some jurisdiction issues — and sparked grumbling that the White House has taken an inconsistent approach to antritrust.

It’s also led to hesitation among providers, with some hospitals suggesting they will balk at ACO participation until the antitrust rules are clarified.

History of Integration

To understand the FTC’s current approach to health care, it’s helpful to revisit the industry’s evolution and regulatory efforts along the way.

Health care merger and acquisition activity may hit record levels in 2011, but the integration wave first crested in the 1990s. Like a Seussian “Butter Battle,” payers and providers have been locked in a decades-long cycle to grow ever larger and marshal negotiating leverage.

On the payer side, a series of mega-mergers has built UnitedHealthcare into the nation’s largest insurer, while WellPoint now insures about one in nine Americans. Meanwhile, hospitals responded to the managed care boom, and its pressure on their prices, by bulking up too. A recent study commissioned by America’s Health Insurance Plans found that 80% of hospital markets were “highly concentrated” as of 2009.

Given their scope, health insurers’ deal-making has tended to attract considerable scrutiny. Between its public prosecution and private investigation, the DOJ has suggested that “health insurer conduct has been among the highest enforcement priorities.” Several major acquisitions in recent decades, like United’s potential merger with Sierra Health Services, were ultimately scuttled because of antitrust scrutiny.

Yet regulators long proved unable — or unwilling — to stop many of the hospital mergers.

After losing six straight hospital merger challenges between 1993 and 1998 — often on grounds that the market was defined too broadly — neither the FTC nor DOJ brought another court case against a prospective hospital merger until 2008. California also lost a prominent 2001 effort to block Sutter Health’s acquisition of Summit Medical Center.

However, regulators’ fortunes changed after the FTC won two challenges in 2008 against Illinois’ Evanston Northwestern Hospital and Virginia’s Inova Health System after adopting a new strategy: use retrospective data to show how hospital mergers ultimately led to higher prices.

A resurgent FTC is now taking on a range of mergers from coast to coast. The agency is reviewing at least 12 cases involving collaboration between competing physician groups or hospitals.

New Approach May Clash With Reform Imperatives

However, federal prosecution is ramping up even as federal law encourages more providers to team up.

According to law firm Epstein Becker Green, 50% to 60% of hospitals and physicians are considering new mergers, consolidations or joint ventures, partly because of incentives in the ACA or other recent federal reforms. For example, some wealthy hospitals are able to subsidize electronic health records purchases for affiliated physician groups under the 2009 stimulus law.

These partnerships can be contagious. A recent report from the Center for Studying Health System Change notes that physicians in markets with high hospital concentration face more pressure “to align closely with one hospital system or another.”

Many organizations say that their M&A activity is intended to align quality goals or create cost efficiencies that will let them succeed under lower reimbursement — a message straight out of the ACA’s mission. But do these partnerships actually boost care and cut spending?

The FTC increasingly doesn’t think so. Such deals “have the potential to generate cost savings and quality benefits,” one senior official told the New York Times‘ Robert Pear, but can end up harming consumers by further concentrating hospital markets.

For example, the agency is battling Ohio-based ProMedica’s potential acquisition of nearby St. Luke’s on grounds that it enhances the system’s already dominant position in the Toledo market. According to ProMedica, the merger would coordinate care and lead to better clinical protocols. The FTC says that the deal is essentially intended to win higher reimbursement rates from private payers.

Some independent economists concur with the FTC’s approach. Austin Frakt of The Incidental Economist blog has warned that hospital consolidation has increased “health care costs by tens of billions per year and, in general, not delivering higher quality.”

Moving Forward

The sector’s consolidation — and the ACA’s impact — is sure to remain a major issue in coming months. A total of $73.7 billion was spent on 243 mergers and acquisitions in the health care industry in the second quarter of 2011, putting M&A “on track to break all previous records” in the market, according to a recent report from Irving Levin Associates.

On Friday, the House Ways & Means Subcommittee on Health will look at how consolidation is affecting health industry prices, with particular attention to health reform’s role. Given that Chair Wally Herger (R-Calif.) has been a prominent advocate of overturning the ACA, it’s likely to be a critical review.

Meanwhile, ACOs are slated to come online in January, and while FTC and DOJ have issued proposed antitrust guidance, they haven’t hammered out a shared policy or who will ultimately prosecute violators.

Here’s what else is making news around the nation.

Rolling Out Reform

Studying the Effects of Reform

Inside the Industry

In Public Opinion

In the States

Challenges to Reform

On the Campaign Trail

Exit mobile version